Resistance to Fas-mediated cell death in BeWo and NJG choriocarcinoma cell lines: implications in immune privilege

By Rajashekhar G.   Loganath A.   Roy A.C.   Mongelli J.M.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 89-100

Elsevier

Access to resources Recommend Favorite

Paclitaxel (Taxol^®)-induced apoptosis in human epithelioid sarcoma cell lines is enhanced by upregulation of CD95 ligand (FasL/Apo-1L)

By Heikaus Sebastian   Matuszek Krystian   Suschek Christoph   Ramp Uwe   Reinecke Petra   Grinstein Edgar   Haremza Janine   Gabbert Helmut   Mahotka Csaba  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 6, 2008-06 ,pp. : 689-695

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of Fas and Fas ligand expression and function in lung cancer cell lines

By Kawasaki M.   Kuwano K.   Nakanishi Y.   Hagimoto N.   Takayama K.   Pei X.-H.   Maeyama T.   Yoshimi M.   Hara N.  

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 656-663

Elsevier

Access to resources Recommend Favorite

Induction of Fas (CD95/APO-1) ligand is essential for p53-dependent apoptosis in an in vitro renal carcinoma model system

By Okazaki Toshihiko   Sakamuro Daitoku  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 9, 2007-09 ,pp. : 581-588

Springer Publishing Company

Access to resources Recommend Favorite

Metallothionein and Fas (CD95) are Expressed in Squamous Cell Carcinoma of the Tongue

By Sundelin K.   Jadner M.   Norberg-Spaak L.   Davidsson A.   Hellquist H.B.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1860-1864

Elsevier

Access to resources Recommend Favorite